(Health-NewsWire.Net, April 12, 2018 ) According to Publisher, the Global Stem Cell Banking Market is accounted for $1.42 billion in 2015 and is expected to reach $4.58 billion by 2022 growing at a CAGR of 18.2% during the forecast period. Growing number of newborns, increasing usage of stem cells in disorder treatment and rising disposable income are some of the factors fueling the market growth. However, huge operating price and regulatory changes are some of the factors hampering the market. Rising awareness about potential use of cord tissue and the automation of procedures are creating opportunities for vendors in the market.
Some of the key players in Stem Cell Banking market include Cordvida, International Stem Cell Corporation, BrainStorm Cell Therapeutics, ReeLabs, Gamida Cell, Cryo Stemcell, Medistem Inc, CordCare, RMS Regrow, Cellular Dynamics International, Arteriocyte, ReNeuron Group, Jeevan Blood Bank Research Center, RhinoCyte, Inc., Cytori Therapeutics, Inc. and StemOne Biologicals.
For more information @ http://www.reportsweb.com/stem-cell-banking-global-market-outlook-2016-2022
Applications Covered: - Leukemia - Cerebral Palsy - Autism - Thalassemia - Diabetes - Other Applications
Bank Types Covered: - Cord Tissue - Cord Blood
Service Types Covered: - Analysis - Collection & Transportation - Storage - Processing
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001564985/sample Regions Covered: - North America o US o Canada o Mexico - Europe o Germany o France o Italy o UK o Spain o Rest of Europe - Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific - Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001564985/buying
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|